Pharmaceuticals
Company Overview of Par Pharmaceutical Companies Inc.
Key Executives for Par Pharmaceutical Companies Inc.
| Name | Board Relationships | Title | Age |
| Paul V. Campanelli | 2 Relationships | Chief Executive Officer and Director | 50 |
| Thomas J. Haughey | 2 Relationships | President and Director | 48 |
| Patrick G. LePore | 13 Relationships | Executive Chairman and Member of Corporate Development Review Committee | 57 |
| Michael A. Tropiano | No Relationships | Chief Financial Officer, Principal Accounting Officer, Executive Vice President and Treasurer | 54 |
Par Pharmaceutical Companies Inc. Board Members*
| Name | Board Relationships | Primary Company | Age |
| Patrick G. LePore | 13 Relationships | Par Pharmaceutical Companies Inc. | 57 |
| Paul V. Campanelli | 2 Relationships | Par Pharmaceutical Companies Inc. | 50 |
| Thomas J. Haughey | 2 Relationships | Par Pharmaceutical Companies Inc. | 48 |
Par Pharmaceutical Companies Inc. Executive Committees*
| Committee Name | Chairperson | Board Relationships | Members | |
| There is no committee data available. | ||||
CEO COMPENSATION IN THIS INDUSTRY
| Industry Range | ||
| Salary | $447.9K | 447.9K 409.1K |
| Bonus | Not meaningful | |
| Total Short Term Compensation | $3.7M | 3.7M 563.2K |
| Total Value of Options | $447.9K | 447.9K 10.5M |
INDUSTRY EXECUTIVE CHANGES
Post a JobJobs
- Greenville, NC | Vidant Medical CenterPosted: May 15
- New Brunswick, NJ | Tridiagonal SolutionsPosted: Apr 24
- Ohio | Boehringer IngelheimPosted: May 05
- Field, KY | Shire PharmaceuticalsPosted: May 18
Sponsored Financial Commentaries
Sponsored Links
To contact Par Pharmaceutical Companies Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








